MD
Mark Donowitz
Principal Investigator
Johns Hopkins Medicine
I'm working on
2 years ago
Nanoparticle-Peptide to treat diarrheal diseases
About
We have used normal human enteroids and in vivo mouse intestine models to develop a nanoparticle-peptide that stimulates intestinal Na and water absorption and reverse fluid secretion of multiple diarrhea models. These techniques have broad applicability for additional diarrhea drug development.
MD
Mark Donowitz
Principal Investigator
Johns Hopkins Medicine
Work experience
Principal Investigator
Top industry applications
Pharmaceuticals and drug delivery
Open to opportunities in
Biological ComplexityCell Membrane TransportDrug DeliveryIntracellular TraffickingMolecular Biology
Last updated Apr 2024
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.